News

EPA Posts Revised Draft OCSPP 810 Series Test Guidelines

EPA released a revised draft of OCSPP 810 Series Test Guidelines in June, now available for public review and comment. Accuratus Lab Services technical personnel have performed an initial review of the draft revisions. Read this summary of some of the significant proposed changes to each of the revised draft guidelines.

Categories: News

Tags: Antimicrobial


Reusable Medical Device Challenges

Reprocessing IFU Development and Validation Reusable medical device manufacturers are required by the U.S. Food and Drug Administration (FDA) to ensure all sets of cleaning instructions are validated and meet the parameters indicated on a device’s labeling. In light of 2015  news items on the use of potentially contaminated endoscopes in Los Angeles, Seattle and Philadelphia.

Categories: News and White Paper

Tags: Cleaning Validation and Reusable Device


Porcine Epidemic Diarrhea Virus (PEDV) Now Available for Testing

ATS Labs is pleased to announce that we have acquired porcine epidemic diarrhea virus (PEDV) and are ready to offer efficacy testing of antimicrobial products against the virus. PEDV is a highly contagious virus from the Cornonaviridae family that, according to the United States Department of Agriculture (USDA), was first isolated in the United Kingdom in 1971 and has now spread across Europe and Asia. The virus was isolated in the United States for the first time in May of 2013; unfortunately the virus has spread nationwide.

Categories: News

Tags: Efficacy Testing


Qualifying Disinfectants for Use in Aseptic Manufacturing

Obtaining the highest confidence that aseptic cleanrooms and other critical manufacturing/quality control (QC) environments are properly disinfected is paramount in assuring the production of safe and effective pharmaceutical products or medical devices.

Categories: News

Tags: Efficacy Testing


ATS Labs Expands to Offer Full Analytical Chemistry Testing Services

Eagan, MN. — December 6, 2013 — ATS Labs, a leading provider of microbiology and virology efficacy testing services to the regulated antimicrobial industry, today announces the launch of its new analytical chemistry testing services. ATS Labs is now able to provide the developers and manufacturers of antimicrobial products with an expanded suite of GLP analytical chemical characterization, physical chemistry and storage stability testing services necessary for the registration of their antimicrobial products.

Categories: News

Tags: Efficacy Testing and GLP


ATS Labs Offers Antimicrobial Testing Utilizing Avian Influenza A (H7N9) Virus

Eagan, MN. — December 6, 2013 — ATS Labs announced today that they are pleased to offer testing of antimicrobial products for efficacy against avian influenza A (H7N9) virus. Avian influenza A (H7N9) virus, called H7N9 for short, has infected humans in China causing severe respiratory illness. According to the United States Centers for Disease Control and Prevention (CDC), approximately one-third of those infected have died.

Categories: News

Tags: Efficacy Testing


Join ATS Labs at the 2013 PDA Annual Conference

Join ATS Labs at the PDA 8th Annual Global Conference on Pharmaceutical Microbiology in Bethesda, Maryland. The conference, hosted at the Betheda North Marriot Hotel, will bring together all levels of industry professionals to network and benefit from a program that reveals the essential science of microbiology and seeks to solve the problems that the global pharmaceutical industry faces on a daily basis.

Categories: News


AOAC Approves, EPA Accepts New Performance Standard and Method Modifications of Use Dilution Test for the Registration of Liquid Disinfectants

The long awaited performance standard changes and method modifications to the AOAC Use Dilution tests for the evaluation of Staphylococcus aureus and Pseudomonas aeruginosa have finally been accepted. Furthermore, the revisions are now accepted by the US EPA for the substantiation of liquid disinfectants.

Categories: News

Tags: Efficacy Testing